G.M. de Lima et al. / Journal of Molecular Structure 988 (2011) 1–8
7
Table 6
Acknowledgements
Minimal inhibitory concentrations (MIC) for complexes (1)–(4), and starting materials
towards C. albicans, S. aureus and P. aeruginosa.
This work was supported by CNPq and FAPEMIG – Brazil. The
authors thank the EPSRC X-ray Crystallographic Service, based at
the University of Southampton, England for the data collections.
ꢀ
3
ꢀ1
[
Cu{S
2
CNR(CH
2 2
CH OH)}
2
]
MIC 10 mmol L
C. albicans
S. aureus
P. aeruginosa
(
(
(
(
1) (R = Me)
2) (R = Et)
3) (R = Pr)
–
–
–
–
17.7
>187
2.2
–
–
–
–
–
References
26.5
36.3
–
32.9
–
4) (R = CH
2
CH
2
OH)
[1] P.J. Heard, Prog. Inorg. Chem. 53 (2005) 1.
[2] G. Hogarth, Prog. Inorg. Chem. 53 (2005) 71.
[3] F.H. Allen, Acta Crystallogr. B 58 (2002) 71.
[4] R.A. Howie, G.M. de Lima, D.C. Menezes, J.L. Wardell, S.M.S. Wardell, D.J. Young,
E.R.T. Tiekink, Chem. Eng. Commun. 10 (2008) 1626.
Tetracycline
Fluconazole
>96.7
–
–
[
Cu(OAc)
2
]ꢁ2H
2
O
–
[
5] A. Radha, M. Seshadayee, K. Radha, D.G. Aravamudan, C.H. Subramanyam, Acta
Crystallogr. E C41 (1985) 1166.
[
[
6] L.-F. Hou, Y. Zhong, Y. Mei, J. Fan, Acta Crystallogr. E E65 (2009) m1694.
7] K. Ramalingam, K. Radha, G. Aravamudan, C. Mahadevan, C. Subramanyam, M.
Seshasayee, Acta Crystallogr. E C40 (1984) 1838.
presence of the Gram-negative S. Aureus both complexes showed
smaller activity than tetracycline and were inert against Gram-po-
sitive P. auruginosa bacteria.
In view of the structures one should not expect great differences
between complexes (1–3), in terms of structure–reactivity
relationship. However, complexes (1) and (2) are inactive towards
the microorganisms used in this study. On the other hand, com-
pound (3) is more effectiveagainst C. albicans than (4) or fluconazole.
[8] R. Nomura, S. Nakamoto, Trans. Mater. Res. Soc. Jpn. 26 (2001) 483.
9] E.R.T. Tiekink, S.M.S.V. Wardell, J.L. Wardell, J. Chem. Crystallogr. 37 (2007)
39.
[
4
[
[
[
10] R.E. Benson, C.A. Ellis, C.E. Lewis, E.R.T. Tiekink, Chem. Eng. Comm. 9 (2007)
930.
11] R.A. Howie, E.R.T. Tiekink, J.L. Wardell, S.M.S.V. Wardell, J. Chem. Crystallogr.
39 (2009) 293.
12] E.R.T. Tiekink, D.J. Young, Acta Crystallogr. E E62 (2006) m1887.
One should expect that the CH
cidal activity, and complex (4), [Cu{S
efficient. However our results show another reality. Complex (3),
2
CH
2
OH group, should enhance bio-
[13] E.R.T. Tiekink, D.J. Young, J. Chem. Crystallogr. 38 (2008) 419.
[
[
[
14] B. Annuar, J.O. Hill, R.J. Magee, J. Inorg. Nucl. Chem. 36 (6) (1974) 1253.
15] B.G. Sejekan, G. Aravamudan, Monatsh. Chem. 109 (1) (1978) 165.
16] S. Singhal, A.N. Garg, K. Chandra, J. Therm. Anal. Calorim. 78 (3) (2004) 941.
2
CN(CH CH OH)} ] the more
2
2
2
[
Cu{S
2
CNR(CH CH
2 2
OH)}
2
] which possesses the less polar R group
[17] D.C. Menezes, G.M. de Lima, F.A. Carvalho, M.G. Coelho, A.O. Porto, R. Augusti,
J.D. Ardisson, Appl. Organomet. Chem. 24 (2010) 650.
(
propyl) is more active than complex (4). We believe it just confirms
[
18] S.T. Breviglieri, E.T.G. Cavalheiro, G.O. Chierice, Thermochim. Acta 356 (2000)
9.
19] B. Annuar, J.O. Hill, R.J. Magee, Thermochim. Acta 8 (1974) 439.
the importance of liposolubility in the drug-cell interaction. Even
though, it is not an easy task to explain the biocidal activities of
metallic complexes such as (1)–(4) frustrating any attempt to
establish a mechanism of action. The anti-fungal activity might be
explained by new interaction of the Cu-based complexes with the
cytoplasmatic membrane. Such interactions with other rich elec-
tronic donor centres, amino-acids, proteins, nucleosides, carbohy-
drates and steroids can increase lipid-solubility assisting the
complexes to cross the cell membrane [60]. In spite of the low activ-
ity towards C. Albicans, the use of metal-based compounds might
represent an alternative therapeutic route to overcome resistance
of the most used drugs such as fluconazole, amphotericin, among
others [60].
7
[
[20] E.F. Hilder, M. Macka, P.R. Haddad, Analyst 123 (1998) 2865.
[
[
21] E.F. Hilder, M. Macka, D. Bogan, P.R. Haddad, Anal. Commun. 34 (1997) 63.
22] J.N. Barisci, G.G. Wallace, E.A. Wilke, M. Meaney, M.R. Smyth, J.G. Vos,
Electroanalysis 1 (1989) 245.
[23] E. Beinrohr, K. Blazsekova, J. Garaj, Collect. Czech. Chem. C. 50 (1985) 1661.
[
[
24] S. Hikime, H. Yoshida, M. Yamamoto, Bunseki Kagaku 10 (1961) 508.
25] A. Cachapa, A. Mederos, P. Gilli, R. Hernandez-Molina, Pedro, S. Dominguez, E.
Chinea, M.L. Rodriguez, M. Feliz, R. Llusar, F. Brito, C.M.R. de Galarreta, C.
Tarbraue, G. Gallardo, Polyhedron 25 (2006) 3366.
[
[
26] A. Mederos, A. Cachapa, R. Hernandez-Molina, M.T. Armas, P. Gili, M. Sokolov, J.
Gonzalez-Platas, F. Brito, Inorg. Chem. Commun. 6 (2003) 498.
27] D.C. Menezes, Main Group Met. Chem. 31 (2008) 21.
[28] D.C. Menezes, F.T. Vieira, G.M. de Lima, A.O. Porto, M.E. Cortés, J.D. Ardisson,
T.E. Albrecht-Schmitt, Eur. J. Med. Chem. 40 (2005) 1277.
[
29] D.C. Menezes, F.T. Vieira, G.M. de Lima, J.L. Wardell, M.E. Cortés, G.A.B. Silva
Ferreira, A. Vilas Boas, J.R. da S. Maia, Appl. Organometal. Chem. 22 (2008) 433.
4
. Conclusions
[30] D.C. Menezes, F.T. Vieira, G.M. de Lima, J.L. Wardell, M.E. Cortes, M.P. Ferreira,
M.A. Soares, A. Vilas Boas, Appl. Organometal. Chem. 22 (2008) 221.
[
31] R.W.W. Hooft, COLLECT, Data Collection Software, Nonius BV, Delft, The
Netherlands, 1998.
2 2 2 2
Complexes [Cu{S CNR(CH CH OH)} ], R = Me (1), Et (2), Pr (3)
and CH
2
CH
2
OH (4), have been prepared and characterised. The
[32] Z. Otwinowski, W. Minor, Processing of X-ray diffraction data collected in
oscillation mode, in: C.W. Carter Jr., R.M. Sweet (Eds.), Methods in
Enzymology, Macromolecular Crystallography, Part A, vol. 276, Academic
Press, New York, 1997, pp. 307–326.
[33] G.M. Sheldrick, SADABS. Version 2.10, Bruker AXS Inc., Madison, Wisconsin,
USA, 2003.
infrared results confirmed the bidentate coordination form of the
ligand. The EPR spectra of (1)–(3) were consistent with a square
pyramidal or square planar geometry with the ground state being
the orbital dx2–y2. Compound (4) has been studied previously by
X-ray [5,6]. The inversion in the g values found in our study can
only be justified if compound (4) has been crystallised as a
distorted square planar molecule, as found previously [6]. Complex
[
34] G.M. Sheldrick, SHELXS-97. Program for the Solution of Crystal Structures,
University of Göttingen, Germany, 1997.
[35] G.M. Sheldrick, SHELXL-97. Program for Crystal Structure Refinement,
University of Göttingen, Germany, 1997.
[
[
36] L.J. Farrugia, J. Appl. Crystallogr. 32 (1999) 837.
37] A.L. Spek, J. Appl. Crystallogr. 36 (2003) 7.
(
2) crystallises as a dimer linked by intermolecular CuAS bonds,
and (3) exists in the solid state in the form of two similar and
independent centrosymmetric monomers. The in vitro activity of
[38] National Committee for Clinical Laboratory Standards, Reference Method for
Broth Dilution Antifungal Susceptibility Testing of Yeasts, second ed.,
Approved Standard. NCCLS Document M27-A2, NCCLS, Pennsylvania, USA,
(
1)–(4) was investigated against colonies of C. albicans, S. aureus
2002, ISBN 1-56238-469-4.
and P. aeruginosa. The biocidal results of (3) and (4) against C. albi-
cans, in terms of MIC (Minimal Inhibitory Concentration), were
quite promising. All complexes were inert in the presence of P.
aeruginosa.
[39] National Committee for Clinical Laboratory Standards, Reference Method for
Broth Dilution Antimicrobial Susceptibility Testing for Bacteria that Grow
Aerobically, sixth ed., Approved Standard. NCCLS Document M7-A6, NCCLS,
Pennsylvania, USA, 2003, ISBN 1-56238-486-4.
[
40] (a) F.W.B. Einstein, J.S. Field, Acta Crystallogr. E B30 (1974) 2928;
b) F. Jian, Z. Wang, Z. Bai, Z. You, H.-K. Fun, K. Chinnakali, I.A. Razak,
(
Polyhedron 18 (1999) 3401.
Supplementary data
[
[
[
41] A. Pignedoli, G. Peyronel, Gazz. Chim. Ital. 92 (1962) 745.
42] G. Peyronel, A. Pignedoli, L. Antolini, Acta Crystallogr. B 28 (1972) 3596.
43] M. Bonamico, G. Dessy, A. Mugnoli, A. Vaciago, L. Zambonelli, Acta Crystallogr.
E 19 (1965) 886.
44] A.M.M. Lanfredi, F. Ugozzoli, A. Camus, J. Chem. Crystallogr. 26 (1996) 141.
[45] E. Kello, V. Kettman, J. Garaj, Coll. Czech. Chem. Commun. 49 (1984) 2210.
Crystallographic data are available on request from: Cambridge
Crystallographic Data Centre on quoting the deposition numbers
CCDC 754825 and 754826 for complexes (2) and (3), respectively.
[